Pravastatin for prevention of HELLP syndrome: A case report.

about

Pravastatin for prevention of HELLP syndrome: A case report.

Item

http://www.wikidata.org/entity/Q47103175

description

2017 nî lūn-bûn

@nan

2017 թվականի հոկտեմբերին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

name

Pravastatin for prevention of HELLP syndrome: A case report.

@en

Pravastatin for prevention of HELLP syndrome: A case report.

@nl

type

Item

label

Pravastatin for prevention of HELLP syndrome: A case report.

@en

Pravastatin for prevention of HELLP syndrome: A case report.

@nl

prefLabel

Pravastatin for prevention of HELLP syndrome: A case report.

@en

Pravastatin for prevention of HELLP syndrome: A case report.

@nl

P1476

Pravastatin for prevention of HELLP syndrome: A case report.

@en

P2093

Katrin van der Ven

http://www.w3.org/2001/XMLSchema#string

Lucia Anna Otten

http://www.w3.org/2001/XMLSchema#string

Marietta Kühr

http://www.w3.org/2001/XMLSchema#string

Ulrich Gembruch

http://www.w3.org/2001/XMLSchema#string

Waltraut Maria Merz

http://www.w3.org/2001/XMLSchema#string

P2860

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

Clinical pharmacokinetics of pravastatin: mechanisms of pharmacokinetic events.

Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model

Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial

Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy

Transplacental transfer and distribution of pravastatin.

Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension.

Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.

Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia.

Effects of pravastatin on mediators of vascular function in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia.

P304

e8229

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1097/MD.0000000000008229

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29049209

http://www.w3.org/2001/XMLSchema#string

P932

5662375

http://www.w3.org/2001/XMLSchema#string